Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$31.57 - $37.73 $50,512 - $60,367
1,600 Added 9.3%
18,800 $702,000
Q1 2023

May 12, 2023

SELL
$29.72 - $41.45 $8,916 - $12,435
-300 Reduced 1.71%
17,200 $20,000
Q4 2022

Feb 14, 2023

SELL
$30.23 - $38.71 $9,069 - $11,613
-300 Reduced 1.69%
17,500 $25,000
Q3 2022

Nov 14, 2022

SELL
$22.51 - $38.27 $150,817 - $256,409
-6,700 Reduced 27.35%
17,800 $12,000
Q2 2022

Aug 12, 2022

BUY
$20.97 - $37.47 $182,439 - $325,989
8,700 Added 55.06%
24,500 $10,000
Q1 2022

May 12, 2022

BUY
$34.38 - $65.77 $543,204 - $1.04 Million
15,800 New
15,800 $31,000
Q4 2020

Feb 16, 2021

SELL
$18.28 - $23.85 $191,940 - $250,425
-10,500 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$12.91 - $18.51 $135,555 - $194,355
10,500 New
10,500 $21,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.